Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease
Name somatostatin is found throughout the gastrointestinal tract and has a wide variety of biological actions. Nevertheless, its short biological half-life and limited stability necessitate its use via continuous parenteral infusion and, thus, limits its therapeutic usefulness The development of lon...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1989-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1989/398524 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403173020631040 |
|---|---|
| author | Richard N. Fedorak |
| author_facet | Richard N. Fedorak |
| author_sort | Richard N. Fedorak |
| collection | DOAJ |
| description | Name somatostatin is found throughout the gastrointestinal tract
and has a wide variety of biological actions. Nevertheless, its short biological
half-life and limited stability necessitate its use via continuous parenteral infusion
and, thus, limits its therapeutic usefulness The development of long acting
somatostatin analogues have lead to a re-examination of the therapeutic usefulness
of somatostatin in gastrointestinal disease. Somatostatin analogues appear
most beneficial tn preventing symptoms associated with neuroendocrine tumours.
In addition, case controlled studies exist to demonstrate somatostatin analogue
effectiveness in treatment of gastrointestinal hemorrhage, pancreatic fistula, pancreatitis,
short bowel syndrome and dumping syndrome. |
| format | Article |
| id | doaj-art-9350308f7d6943b990cd29fed17b045d |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 1989-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-9350308f7d6943b990cd29fed17b045d2025-08-20T03:37:20ZengWileyCanadian Journal of Gastroenterology0835-79001989-01-0132778110.1155/1989/398524Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal DiseaseRichard N. Fedorak0Department of Medicine, Division of Gastroentrology, University of Alberta, Edmonton, Alberta, CanadaName somatostatin is found throughout the gastrointestinal tract and has a wide variety of biological actions. Nevertheless, its short biological half-life and limited stability necessitate its use via continuous parenteral infusion and, thus, limits its therapeutic usefulness The development of long acting somatostatin analogues have lead to a re-examination of the therapeutic usefulness of somatostatin in gastrointestinal disease. Somatostatin analogues appear most beneficial tn preventing symptoms associated with neuroendocrine tumours. In addition, case controlled studies exist to demonstrate somatostatin analogue effectiveness in treatment of gastrointestinal hemorrhage, pancreatic fistula, pancreatitis, short bowel syndrome and dumping syndrome.http://dx.doi.org/10.1155/1989/398524 |
| spellingShingle | Richard N. Fedorak Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease Canadian Journal of Gastroenterology |
| title | Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease |
| title_full | Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease |
| title_fullStr | Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease |
| title_full_unstemmed | Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease |
| title_short | Long Acting Somatostatin Analogue: Clinical Potential for Gastrointestinal Disease |
| title_sort | long acting somatostatin analogue clinical potential for gastrointestinal disease |
| url | http://dx.doi.org/10.1155/1989/398524 |
| work_keys_str_mv | AT richardnfedorak longactingsomatostatinanalogueclinicalpotentialforgastrointestinaldisease |